Bormioli Pharma continues to invest in advancement of German hub

The plant in Bad Königshofen to double production by 2023

Bormioli Pharma continues to invest in the advancement of its German hub for excellence in tubing glass conversion. In order to satisfy a growing market demand and ensure business continuity to its clients, the company has enforced production capability and expanded the clean rooms.

Why to choose Bormioli Pharma tubing glass vials
• High quality and maximum production performance
• Solutions suitable for different application, from parenteral to oral solid and chromatography

Why to choose Bormioli Pharma
• Two German dedicated plants to ensure business continuity
• Constant investments in production technologies and capability

What’s coming next?
• Doubling of production capacity at the Bad Königshofen plant by 2023